Mark Zupancic

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Locally Advanced

Squamous Cell Carcinoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Lars Sivars, Cecilia Jylhä, Ylva Crona Guterstam, Mark Zupancic, Britta Lindqvist, Magnus Nordenskjöld, Emma Tham, Kristina Hellman
Cell-free human papillomavirus (HPV) DNA is a sensitive biomarker for prognosis and for early detection of relapse in locally advanced cervical cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Lars Sivars, Cecilia Jylhä, Ylva Crona Guterstam, Mark Zupancic, Britta Lindqvist, Magnus Nordenskjöld, Emma Tham, Kristina Hellman
Cell-Free Human Papillomavirus DNA Is a Sensitive Biomarker for Prognosis and for Early Detection of Relapse in Locally Advanced Cervical Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (13) (2024)
Mark Zupancic, Anders Näsman, Anders Berglund, Tina Dalianis, Signe Friesland
Adenoid Cystic Carcinoma (AdCC): A Clinical Survey of a Large Patient Cohort. Cancers 15 (5) (2023)
Caroline Haglund de Flon, Linnea Haeggblom, Stefan Holzhauser, Ourania N Kostopoulou, Mark Zupancic, Tina Dalianis, Eva Munck-Wikland, Linda Marklund, Anders Näsman
High Levels of FGF11 Correlate with Poor Survival in Patients with Human Papillomavirus (HPV)-Positive Oropharyngeal Squamous Cell Carcinoma. Cancers 15 (7) (2023)
Mark Zupancic, Anders Näsman, Anders Berglund, Tina Dalianis, Signe Friesland
Adenoid Cystic Carcinoma (AdCC): A Clinical Survey of a Large Patient Cohort. Cancers 15 (5) (2023)
Karin Byskata, Monika Lukoseviciute, Filippo Tuti, Mark Zupancic, Ourania N Kostopoulou, Stefan Holzhauser, Tina Dalianis
Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited. Cancers 15 (1) (2022)
Karin Byskata, Monika Lukoseviciute, Filippo Tuti, Mark Zupancic, Ourania N Kostopoulou, Stefan Holzhauser, Tina Dalianis
Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited. Cancers 15 (1) (2022)
Karin Byskata, Monika Lukoseviciute, Filippo Tuti, Mark Zupancic, Ourania N Kostopoulou, Stefan Holzhauser, Tina Dalianis
Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited. Cancers 15 (1) (2022)
Ourania N Kostopoulou, Mark Zupancic, Mariona Pont, Emma Papin, Monika Lukoseviciute, Borja Agirre Mikelarena, Stefan Holzhauser, Tina Dalianis
Targeted Therapy of HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy between CDK4/6, PI3K and Sometimes FGFR Inhibitors, but Rarely between PARP and WEE1 Inhibitors. Viruses 14 (7) (2022)